197 related articles for article (PubMed ID: 30646853)
1. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis.
Nie D; Yang E; Li Z
BMC Cancer; 2019 Jan; 19(1):73. PubMed ID: 30646853
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
[TBL] [Abstract][Full Text] [Related]
3. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer.
Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T
Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population.
Gorelick C; Andikyan V; Mack M; Lee YC; Abulafia O
Int J Gynecol Cancer; 2009 Nov; 19(8):1384-9. PubMed ID: 20009894
[TBL] [Abstract][Full Text] [Related]
5. High L1CAM expression predicts poor prognosis of patients with endometrial cancer: A systematic review and meta-analysis.
Guo M; Gong H; Nie D; Li Z
Medicine (Baltimore); 2021 Apr; 100(13):e25330. PubMed ID: 33787629
[TBL] [Abstract][Full Text] [Related]
6. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma.
Abu-Zaid A; Alsabban M; Abuzaid M; AlOmar O; Salem H; Al-Badawi IA
Ann Saudi Med; 2017; 37(5):393-400. PubMed ID: 28988254
[TBL] [Abstract][Full Text] [Related]
7. Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy?
Vrede SW; Donkers H; Reijnen C; Smits A; Visser NCM; Geomini PM; Ngo H; van Hamont D; Pijlman BM; Vos MC; Snijders MPLM; Kruitwagen R; Bekkers RLM; Galaal K; Pijnenborg JMA
J Obstet Gynaecol; 2024 Dec; 44(1):2294332. PubMed ID: 38186008
[TBL] [Abstract][Full Text] [Related]
8. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
[TBL] [Abstract][Full Text] [Related]
9. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer.
Heng S; Benjapibal M
Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452
[TBL] [Abstract][Full Text] [Related]
10. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis.
Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA
Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973
[TBL] [Abstract][Full Text] [Related]
11. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas.
Njølstad TS; Engerud H; Werner HM; Salvesen HB; Trovik J
Gynecol Oncol; 2013 Nov; 131(2):410-5. PubMed ID: 24004646
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in endometrial cancer: a systematic review and meta-analysis.
Ni L; Tao J; Xu J; Yuan X; Long Y; Yu N; Wu R; Zhang Y
Arch Gynecol Obstet; 2020 Jan; 301(1):251-261. PubMed ID: 31768743
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis.
Cao W; Yao X; Cen D; Zhi Y; Zhu N; Xu L
World J Surg Oncol; 2019 Aug; 17(1):132. PubMed ID: 31375109
[TBL] [Abstract][Full Text] [Related]
14. Pre-treatment thrombocytosis predicts prognosis of endometrial cancer: A meta-analysis of 11 studies.
Ye Q; Wu Z; Xia T; Liu D; Yang Y; Tang H
Exp Ther Med; 2020 Jan; 19(1):359-366. PubMed ID: 31853312
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis.
Zhuo Y; Lin L; Zhang M
Platelets; 2017 Sep; 28(6):560-566. PubMed ID: 27848258
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis.
Bai YY; Du L; Jing L; Tian T; Liang X; Jiao M; Nan KJ; Guo H; Ruan ZP
Cancer Manag Res; 2019; 11():4283-4295. PubMed ID: 31190994
[No Abstract] [Full Text] [Related]
17. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
18. Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.
Ye Q; Cheng J; Ye M; Liu D; Zhang Y
J Gynecol Oncol; 2019 Jan; 30(1):e5. PubMed ID: 30479089
[TBL] [Abstract][Full Text] [Related]
19. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.
Cheng J; Zeng Z; Ye Q; Zhang Y; Yan R; Liang C; Wang J; Li M; Yi M
Oncotarget; 2017 Apr; 8(15):24327-24336. PubMed ID: 28212582
[TBL] [Abstract][Full Text] [Related]
20. Thrombocytosis as a prognostic factor in endometrial carcinoma.
Gücer F; Moser F; Tamussino K; Reich O; Haas J; Arikan G; Petru E; Winter R
Gynecol Oncol; 1998 Aug; 70(2):210-4. PubMed ID: 9740692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]